Racial Differences in Essential Tremor
Objective: To study racial differences in a cohort of Veterans experiencing Essential Tremor. Background: Health disparities are quite widespread and there are numerous efforts going…Dopaminergic Denervation as Predictors of Falls in PD Patients
Objective: We aimed to predict fall risk in PD patients using SBR data obtained from PPMI. Background: While dopamine is currently considered to be the…Apomorphine sublingual film patient-reported motor status response at home throughout the day
Objective: To assess the efficacy throughout the day of self-administered apomorphine sublingual film (SL-APO) compared with placebo (PLC) for the treatment of OFF episodes in…Feasibility of using wearable sensors to monitor activity and sleep patterns in inpatients with delirium and Parkinson’s disease
Objective: To assess the feasibility of using wearable sensors in Parkinson's disease (PD) inpatients with/without delirium and to quantify clinically relevant digital outcomes to facilitate…Monitoring disease course by sensor-based gait analysis: gait symmetry and motor impairment progression in Parkinson’s disease.
Objective: Evaluate gait symmetry index as progression marker for motor impairment in patients with Parkinson’s disease (PD). Background: PD is a neurodegenerative disease characterized by…Conservative iron chelation for Neuroferritinopathy
Objective: Evaluate the safety and efficacy of a conservative mode of iron chelation with deferiprone 30 mg/kg/day in neuroferritinopathy to limit iron-related neurodegeneration and associated…Repetitive Transcranial Magnetic Stimulation to the Inferior Parietal Lobule in Task-Specific Focal Hand Dystonia: A Randomized Crossover Blinded Outcome Assessment Study
Objective: We used repetitive transcranial magnetic stimulation to test the hypothesis that an inhibitory protocol to the left inferior parietal lobule in right-handed patients with…Is there a role for safinamide in atypical parkinsonian syndromes?
Objective: To search for possible benefits of safinamide in atypical parkinsonism. Background: Safinamide is a selective reversible monoamine oxidase-B inhibitor with both dopaminergic and glutamatergic…Expanding the services of Neurogenetic Clinic – Lessons learnt from Cerebellar Ataxia cohort
Objective: We present an overview of patients seen by our Neurogenetic Clinic since 2019, focusing on the cerebellar ataxia (CA) cohort. Background: Diagnostic yield of…mGlu3 receptors in Parkinson’s disease as a candidate target for neuroprotective therapy: evidence from preclinical studies to human genetic.
Objective: In a toxicological model of mouse parkinsonism through chronic injection of MPTP, we examined whether the presence or absence of mGlu3 receptors affected neurodegeneration…
- « Previous Page
- 1
- …
- 134
- 135
- 136
- 137
- 138
- …
- 153
- Next Page »